Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #457164 on NorthWest Biotherapeutics Inc (NWBO)
sentiment_stocks
04/06/22 2:33 AM
#457171 RE: hyperopia #457164
That should tell everyone just how significant it would be for DCVax to be added as a front-line, Standard of Care for both ndGBM and rGBM. Kite is competing with Novartis and other new upcoming treatments for a second-line and third-line setting for a relatively small market. (and still able to make $1B in sales) Meanwhile, Northwest Bio is basically set to own the brain-tumor market!